Letermovir prophylaxis timing in standard-risk and very high-risk adult CMV-seropositive allogeneic hematopoietic stem cell transplant recipients: A systematic literature review. (PubMed, J Clin Virol) - May 18, 2026 - "In summary, this descriptive systematic review highlights practice patterns and directional trends suggesting potential benefits of earlier letermovir initiation in standard-risk allo-HSCT recipients, while underscoring the need for individualized strategies and further prospective evaluation in very high-risk populations. REGISTRATION: PROSPERO (CRD42024573330)."
Journal • Review • Bone Marrow Transplantation • Cytomegalovirus Infection • Infectious Disease • Transplantation
|
|
Jiaxian Guo; Luxiang Wang; Xiaoxia Hu; Yi Sun
|